Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19.
PLoS One.
2024;19(8):e0285638. doi: 10.1371/journal.pone.0285638. eCollection 2024. PubMed PMID:
39106254; PubMed Central PMCID:
PMC11302896.
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in ARDS.
Am J Respir Cell Mol Biol.
2024 Jul 1;. doi: 10.1165/rcmb.2024-0201OC. [Epub ahead of print] PubMed PMID:
38950166.
SEESAW: detecting isoform-level allelic imbalance accounting for inferential uncertainty.
Genome Biol.
2023 Jul 12;24(1):165. doi: 10.1186/s13059-023-03003-x. PubMed PMID:
37438847; PubMed Central PMCID:
PMC10337143.
Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a- and Siglece-based vaccination induces anti-tumor immunity and inhibits metastasis.
bioRxiv.
2023 May 10;. doi: 10.1101/2023.05.09.539617. PubMed PMID:
37214884; PubMed Central PMCID:
PMC10197572.
The trouble with triples: Examining the impact of measurement error in mediation analysis.
Genetics.
2023 May 4;224(1). doi: 10.1093/genetics/iyad045. PubMed PMID:
36932658; PubMed Central PMCID:
PMC10158839.
Immune Mechanisms in Inflammatory Anemia.
Annu Rev Immunol.
2023 Apr 26;41:405-429. doi: 10.1146/annurev-immunol-101320-125839. Epub 2023 Feb 7. Review. PubMed PMID:
36750316; PubMed Central PMCID:
PMC10367595.
Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis.
Blood.
2022 Oct 6;140(14):1621-1634. doi: 10.1182/blood.2022015724. PubMed PMID:
35862735; PubMed Central PMCID:
PMC9707396.
Detection of neutrophil extracellular traps in patient plasma: method development and validation in systemic lupus erythematosus and healthy donors that carry IRF5 genetic risk.
Front Immunol.
2022;13:951254. doi: 10.3389/fimmu.2022.951254. eCollection 2022. PubMed PMID:
35958624; PubMed Central PMCID:
PMC9360330.
Neutrophil phenotypes and functions in cancer: A consensus statement.
J Exp Med.
2022 Jun 6;219(6). doi: 10.1084/jem.20220011. Epub 2022 May 6. Review. PubMed PMID:
35522219; PubMed Central PMCID:
PMC9086501.
HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation.
Blood.
2022 May 26;139(21):3181-3193. doi: 10.1182/blood.2021012048. PubMed PMID:
35040907; PubMed Central PMCID:
PMC9136881.
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.
Arthritis Rheumatol.
2021 Dec;73(12):2206-2218. doi: 10.1002/art.41953. Epub 2021 Nov 1. PubMed PMID:
34423919; PubMed Central PMCID:
PMC8671219.
Signals governing monocyte differentiation during inflammation.
Curr Opin Immunol.
2021 Dec;73:16-24. doi: 10.1016/j.coi.2021.07.007. Epub 2021 Aug 16. Review. PubMed PMID:
34411882; PubMed Central PMCID:
PMC8648978.
Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.
Arthritis Rheumatol.
2021 Aug;73(8):1467-1477. doi: 10.1002/art.41677. Epub 2021 Jul 7. PubMed PMID:
33559374; PubMed Central PMCID:
PMC8324518.
Intracellular IRF5 Dimerization Assay.
Bio Protoc.
2021 May 20;11(10):e4021. doi: 10.21769/BioProtoc.4021. eCollection 2021 May 20. PubMed PMID:
34150928; PubMed Central PMCID:
PMC8187113.
Frontline Science: AMPK regulates metabolic reprogramming necessary for interferon production in human plasmacytoid dendritic cells.
J Leukoc Biol.
2021 Feb;109(2):299-308. doi: 10.1002/JLB.3HI0220-130. Epub 2020 Jul 8. PubMed PMID:
32640499.
Inhibition of IRF5 hyperactivation protects from lupus onset and severity.
J Clin Invest.
2020 Dec 1;130(12):6700-6717. doi: 10.1172/JCI120288. PubMed PMID:
32897883; PubMed Central PMCID:
PMC7685739.
The Versatility of Sirtuin-1 in Endocrinology and Immunology.
Front Cell Dev Biol.
2020;8:589016. doi: 10.3389/fcell.2020.589016. eCollection 2020. Review. PubMed PMID:
33330467; PubMed Central PMCID:
PMC7717970.
B Cell αv Integrins Regulate TLR-Driven Autoimmunity.
J Immunol.
2020 Oct 1;205(7):1810-1818. doi: 10.4049/jimmunol.1901056. Epub 2020 Aug 28. PubMed PMID:
32859730; PubMed Central PMCID:
PMC7504890.
Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series.
Mol Med.
2020 Sep 29;26(1):91. doi: 10.1186/s10020-020-00215-w. PubMed PMID:
32993479; PubMed Central PMCID:
PMC7522910.
CD4 T Follicular Helper Cells Prevent Depletion of Follicular B Cells in Response to Cecal Ligation and Puncture.
Front Immunol.
2020;11:1946. doi: 10.3389/fimmu.2020.01946. eCollection 2020. PubMed PMID:
32903485; PubMed Central PMCID:
PMC7434988.
Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
Cytokine.
2020 Aug;132:154731. doi: 10.1016/j.cyto.2019.05.018. Epub 2019 May 23. Review. PubMed PMID:
31130331.
T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.
Cell Rep.
2020 Jun 30;31(13):107820. doi: 10.1016/j.celrep.2020.107820. PubMed PMID:
32610123; PubMed Central PMCID:
PMC7409536.
Neutrophil extracellular traps in COVID-19.
JCI Insight.
2020 Jun 4;5(11). doi: 10.1172/jci.insight.138999. PubMed PMID:
32329756; PubMed Central PMCID:
PMC7308057.
Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function.
Front Immunol.
2020;11:1143. doi: 10.3389/fimmu.2020.01143. eCollection 2020. Review. PubMed PMID:
32582209; PubMed Central PMCID:
PMC7283537.
Targeting potential drivers of COVID-19: Neutrophil extracellular traps.
J Exp Med.
2020 Jun 1;217(6). doi: 10.1084/jem.20200652. PubMed PMID:
32302401; PubMed Central PMCID:
PMC7161085.
Modulating Cytokine Production via Select Packaging and Secretion From Extracellular Vesicles.
Front Immunol.
2020;11:1040. doi: 10.3389/fimmu.2020.01040. eCollection 2020. Review. PubMed PMID:
32547552; PubMed Central PMCID:
PMC7272603.
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization.
Sci Adv.
2020 May;6(20):eaay1057. doi: 10.1126/sciadv.aay1057. eCollection 2020 May. PubMed PMID:
32440537; PubMed Central PMCID:
PMC7228753.
Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series.
medRxiv.
2020 May 15;. doi: 10.1101/2020.05.13.20087734. PubMed PMID:
32511514; PubMed Central PMCID:
PMC7273282.
Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19.
medRxiv.
2020 Apr 14;. doi: 10.1101/2020.04.09.20059626. PubMed PMID:
32511633; PubMed Central PMCID:
PMC7276989.
IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
JCI Insight.
2020 Jan 30;5(2). doi: 10.1172/jci.insight.124020. PubMed PMID:
31877114; PubMed Central PMCID:
PMC7098722.
HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis.
Proc Natl Acad Sci U S A.
2019 Nov 12;116(46):23254-23263. doi: 10.1073/pnas.1907490116. Epub 2019 Sep 30. PubMed PMID:
31570601; PubMed Central PMCID:
PMC6859319.
RNAi Transfection Optimized in Primary Naïve B Cells for the Targeted Analysis of Human Plasma Cell Differentiation.
Front Immunol.
2019;10:1652. doi: 10.3389/fimmu.2019.01652. eCollection 2019. PubMed PMID:
31396212; PubMed Central PMCID:
PMC6664017.
Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.
Curr Rheumatol Rep.
2019 Jan 15;21(1):2. doi: 10.1007/s11926-019-0803-3. Review. PubMed PMID:
30645688.
Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes.
Science.
2019 Jan 11;363(6423). doi: 10.1126/science.aao5213. PubMed PMID:
30630901; PubMed Central PMCID:
PMC6413693.
Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?.
Front Immunol.
2018;9:2622. doi: 10.3389/fimmu.2018.02622. eCollection 2018. Review. PubMed PMID:
30515152; PubMed Central PMCID:
PMC6255967.
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.
Breast Cancer Res.
2018 Nov 20;20(1):138. doi: 10.1186/s13058-018-1063-2. PubMed PMID:
30458886; PubMed Central PMCID:
PMC6245538.
Corrected and Republished from: The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability.
Mol Cell Biol.
2018 Feb 1;38(3). doi: 10.1128/MCB.00493-17. Print 2018 Feb 1. PubMed PMID:
29339435; PubMed Central PMCID:
PMC5770539.
B Cell-Intrinsic Role for IRF5 in TLR9/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation.
Front Immunol.
2017;8:1938. doi: 10.3389/fimmu.2017.01938. eCollection 2017. PubMed PMID:
29367853; PubMed Central PMCID:
PMC5768180.
Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
J Biol Chem.
2017 Dec 29;292(52):21676-21689. doi: 10.1074/jbc.M117.792721. Epub 2017 Oct 27. PubMed PMID:
29079574; PubMed Central PMCID:
PMC5766933.
Interferon regulatory factor signaling in autoimmune disease.
Cytokine.
2017 Oct;98:15-26. doi: 10.1016/j.cyto.2017.02.006. Epub 2017 Mar 7. Review. PubMed PMID:
28283223; PubMed Central PMCID:
PMC8033540.
Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality.
Sci Rep.
2016 Aug 2;6:31002. doi: 10.1038/srep31002. PubMed PMID:
27481535; PubMed Central PMCID:
PMC4969615.
Constitutive expression of IRF-5 in HTLV-1-infected T cells.
Int J Oncol.
2015 Jul;47(1):361-9. doi: 10.3892/ijo.2015.3020. Epub 2015 May 22. PubMed PMID:
26004104.
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
Immunol Cell Biol.
2015 May-Jun;93(5):486-99. doi: 10.1038/icb.2014.110. Epub 2014 Dec 23. PubMed PMID:
25533286.
A conserved region within interferon regulatory factor 5 controls breast cancer cell migration through a cytoplasmic and transcription-independent mechanism.
Mol Cancer.
2015 Feb 4;14(1):32. doi: 10.1186/s12943-015-0305-5. PubMed PMID:
25649192; PubMed Central PMCID:
PMC4326371.
TRIpartite motif 21 (TRIM21) differentially regulates the stability of interferon regulatory factor 5 (IRF5) isoforms.
PLoS One.
2014;9(8):e103609. doi: 10.1371/journal.pone.0103609. eCollection 2014. PubMed PMID:
25084355; PubMed Central PMCID:
PMC4118895.
Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Oncogene.
2014 Jun 19;33(25):3288-97. doi: 10.1038/onc.2013.295. Epub 2013 Aug 5. PubMed PMID:
23912454.
Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers.
Cancers (Basel).
2014 Apr 23;6(2):969-97. doi: 10.3390/cancers6020969. PubMed PMID:
24762633; PubMed Central PMCID:
PMC4074812.
Editorial: are regulatory B10 cells a viable target for autoimmune diseases?.
J Leukoc Biol.
2013 Oct;94(4):548-50. doi: 10.1189/jlb.0513267. PubMed PMID:
24082049.
Bioinformatics analysis of the factors controlling type I IFN gene expression in autoimmune disease and virus-induced immunity.
Front Immunol.
2013;4:291. doi: 10.3389/fimmu.2013.00291. eCollection 2013. PubMed PMID:
24065968; PubMed Central PMCID:
PMC3776951.
The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.
Mol Cell Biol.
2013 Mar;33(6):1124-38. doi: 10.1128/MCB.00802-12. Epub 2012 Dec 28. PubMed PMID:
23275442; PubMed Central PMCID:
PMC3592028.
What would you like to do?